UROTHELIAL CARCINOMA

This study tested several drug combinations given before bladder removal surgery for people with muscle-invasive bladder cancer who could not take the standard chemotherapy drug cisplatin. The goal was to see if these treatments could boost immune cells in the tumor. The study wa…

This study tested a new drug called OC-001, given alone or with an immunotherapy drug (Avelumab), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The study was stopped early and involved 73 participants with v…

This study tested a new drug called PRO1107 in 33 people with advanced solid tumors, including ovarian, endometrial, and lung cancers. The goal was to check safety and see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This study tested whether adding trilaciclib to standard chemotherapy and maintenance therapy could help people with advanced bladder cancer. The trial was stopped early, so results are limited. It involved 92 adults with untreated, advanced or metastatic urothelial carcinoma.

This early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors like lung, stomach, bladder, kidney, colon, or esophageal cancer that had come back or spread. The main goal was to find the safest dose and understand how the drug works in the body. T…

This early-stage study tested a new experimental drug (PF-07820435) alone or with another drug (sasanlimab) in people with advanced solid tumors like lung, skin, and kidney cancers. The goal was to check safety and find the right dose. Only 9 people took part before the study was…